Public Health Researchers Awarded $10.7M for Alzheimer’s Research

Ilyas Kamboh in a black suit

Despite decades of research and investment, the genetic underpinnings of Alzheimer’s disease are still largely unknown, stymieing drug development and early diagnosis efforts. A new $10.7 million, five-year project led by the University of Pittsburgh Graduate School of Public Health and Washington University School of Medicine in St. Louis aims to change that with the first comprehensive study using whole genome sequencing to address a critical gap in knowledge about the disease.

With funding from the National Institute on Aging, the research team plans to identify the genetic variants, genes and pathways that lead to formation of plaques and tangles, two specific biomarkers that begin accumulating in the brains of people with Alzheimer’s 15 to 25 years before they show symptoms. 

Read more about the grant and researcher Ilyas Kamboh, professor of human genetics and epidemiology.